Form 8-K - Current report:
SEC Accession No. 0001193125-20-286266
Filing Date
2020-11-05
Accepted
2020-11-05 08:00:52
Documents
2
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d74332d8k.htm 8-K 16885
2 EX-99.1 d74332dex991.htm EX-99.1 71038
  Complete submission text file 0001193125-20-286266.txt   89110
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38959 | Film No.: 201288761
SIC: 2834 Pharmaceutical Preparations